
    
      Part A of this study will determine the Maximum Tolerated Dose of Debio 0932 in combination
      with cisplatin/pemetrexed and cisplatin/gemcitabine in treatment-na√Øve patients with Stage
      IIIb or IV NSCLC, and with docetaxel in previously treated patients with Stage IIIb or IV
      NSCLC.

      Escalating doses of Debio 0932 will be given to subsequent patients in combination with
      standard doses of these 3 background chemotherapies.
    
  